Liver transplantation during infancy: No increased rate of neurological complications

pLT is a highly standardized therapy for children with end‐stage liver disease and liver‐based metabolic diseases. However, NCs after transplantation occur and especially younger children are considered as more vulnerable and susceptible to NCs. Up to now, detailed data particularly for the very you...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric transplantation 2018-12, Vol.22 (8), p.e13304-n/a
Hauptverfasser: Ameres, Markus, Melter, Michael, Zant, Robert, Schilling, Stefan, Geis, Tobias
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page n/a
container_issue 8
container_start_page e13304
container_title Pediatric transplantation
container_volume 22
creator Ameres, Markus
Melter, Michael
Zant, Robert
Schilling, Stefan
Geis, Tobias
description pLT is a highly standardized therapy for children with end‐stage liver disease and liver‐based metabolic diseases. However, NCs after transplantation occur and especially younger children are considered as more vulnerable and susceptible to NCs. Up to now, detailed data particularly for the very young age group do not exist. We therefore retrospectively studied NCs in children after pLT under age of 24 months. Forty children aged between 19 days and 22 months were evaluated according to type of NC and potential risk factors. NCs occurred in 8/40 patients (20%). All experienced new‐onset seizures and in 1/6 surviving patients, seizures evolved into epilepsy. Other NCs were intracerebral abscess (1/8 patients) and subdural hemorrhage (1/8 patients). The overall 3‐year mortality rate was 10% (4/40 patients). Significant risk factors for NCs and therefore seizures were HAT (P = 0.020), total surgery time (P = 0.009), retransplantation (P 
doi_str_mv 10.1111/petr.13304
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2119930740</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2119930740</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3574-d1f08cc9bd89b4b3a803bdadce0589e0e92c090a03b32e9f00317f9a0c2e8bf43</originalsourceid><addsrcrecordid>eNp9kE9Lw0AQxRdRrFYvfgAJeBEhdTa7abLepNQ_UFSkPYfNZrakpNm4myj99m6b6sGDc5nH8JvHzCPkgsKI-rptsLUjyhjwA3JCmRChl-PDnU5CRnk0IKfOrQDomKf8mAwYMBqPqTghi1n5iTZoraxdU8m6lW1p6qDobFkvg7LWslabu-DFeK0sSodFYGWLgdFBjZ01lVmWSlaBMuum8mq77s7IkZaVw_N9H5LFw3Q-eQpnr4_Pk_tZqFic8LCgGlKlRF6kIuc5kymwvJCFQohTgYAiUiBA-imLUGjwZydaSFARprnmbEiue9_Gmo8OXZutS6ew8o-g6VwWUSoEg4SDR6_-oCvT2dpf5ykm4phxSDx101PKGucs6qyx5VraTUYh24adbcPOdmF7-HJv2eVrLH7Rn3Q9QHvgq6xw849V9jadv_em39aKioM</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2139553407</pqid></control><display><type>article</type><title>Liver transplantation during infancy: No increased rate of neurological complications</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ameres, Markus ; Melter, Michael ; Zant, Robert ; Schilling, Stefan ; Geis, Tobias</creator><creatorcontrib>Ameres, Markus ; Melter, Michael ; Zant, Robert ; Schilling, Stefan ; Geis, Tobias</creatorcontrib><description>pLT is a highly standardized therapy for children with end‐stage liver disease and liver‐based metabolic diseases. However, NCs after transplantation occur and especially younger children are considered as more vulnerable and susceptible to NCs. Up to now, detailed data particularly for the very young age group do not exist. We therefore retrospectively studied NCs in children after pLT under age of 24 months. Forty children aged between 19 days and 22 months were evaluated according to type of NC and potential risk factors. NCs occurred in 8/40 patients (20%). All experienced new‐onset seizures and in 1/6 surviving patients, seizures evolved into epilepsy. Other NCs were intracerebral abscess (1/8 patients) and subdural hemorrhage (1/8 patients). The overall 3‐year mortality rate was 10% (4/40 patients). Significant risk factors for NCs and therefore seizures were HAT (P = 0.020), total surgery time (P = 0.009), retransplantation (P &lt; 0.001), period of catecholamine therapy (P = 0.024), period of mechanical ventilation (P = 0.014), and period of sedation (P = 0.010). Our study is the first to provide detailed information on NCs after pLT in children under 24 months of age. The incidence of NCs in this particular group of very young patients was not increased compared to previously published data of children of all ages. Main NC was new‐onset seizure. In the surviving infants, prognosis of seizure was excellent and the risk of developing epilepsy was low. Even more, the occurrence of NCs did not significantly affect mortality or survival in this particular age group.</description><identifier>ISSN: 1397-3142</identifier><identifier>EISSN: 1399-3046</identifier><identifier>DOI: 10.1111/petr.13304</identifier><identifier>PMID: 30315619</identifier><language>eng</language><publisher>Denmark: Wiley Subscription Services, Inc</publisher><subject>Age ; Brain Abscess - complications ; Catecholamines ; Catecholamines - therapeutic use ; Children ; Convulsions &amp; seizures ; End Stage Liver Disease - complications ; End Stage Liver Disease - surgery ; Epilepsy ; Female ; Hematoma, Subdural - complications ; Hemorrhage ; Humans ; Incidence ; Infant ; Infant, Newborn ; Infants ; Liver diseases ; Liver transplantation ; Liver Transplantation - adverse effects ; Liver transplants ; Male ; Mechanical ventilation ; Medical prognosis ; Mortality ; Nervous System Diseases - complications ; Neurological complications ; Respiration, Artificial ; Retrospective Studies ; Risk Factors ; seizure ; Seizures ; Seizures - complications ; Surgery</subject><ispartof>Pediatric transplantation, 2018-12, Vol.22 (8), p.e13304-n/a</ispartof><rights>2018 Wiley Periodicals, Inc.</rights><rights>2018 John Wiley &amp; Sons A/S. Published by John Wiley &amp; Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3574-d1f08cc9bd89b4b3a803bdadce0589e0e92c090a03b32e9f00317f9a0c2e8bf43</citedby><cites>FETCH-LOGICAL-c3574-d1f08cc9bd89b4b3a803bdadce0589e0e92c090a03b32e9f00317f9a0c2e8bf43</cites><orcidid>0000-0002-6941-3247 ; 0000-0001-8092-3590 ; 0000-0002-4194-0758 ; 0000-0003-0604-332X ; 0000-0001-5053-5618</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpetr.13304$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpetr.13304$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30315619$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ameres, Markus</creatorcontrib><creatorcontrib>Melter, Michael</creatorcontrib><creatorcontrib>Zant, Robert</creatorcontrib><creatorcontrib>Schilling, Stefan</creatorcontrib><creatorcontrib>Geis, Tobias</creatorcontrib><title>Liver transplantation during infancy: No increased rate of neurological complications</title><title>Pediatric transplantation</title><addtitle>Pediatr Transplant</addtitle><description>pLT is a highly standardized therapy for children with end‐stage liver disease and liver‐based metabolic diseases. However, NCs after transplantation occur and especially younger children are considered as more vulnerable and susceptible to NCs. Up to now, detailed data particularly for the very young age group do not exist. We therefore retrospectively studied NCs in children after pLT under age of 24 months. Forty children aged between 19 days and 22 months were evaluated according to type of NC and potential risk factors. NCs occurred in 8/40 patients (20%). All experienced new‐onset seizures and in 1/6 surviving patients, seizures evolved into epilepsy. Other NCs were intracerebral abscess (1/8 patients) and subdural hemorrhage (1/8 patients). The overall 3‐year mortality rate was 10% (4/40 patients). Significant risk factors for NCs and therefore seizures were HAT (P = 0.020), total surgery time (P = 0.009), retransplantation (P &lt; 0.001), period of catecholamine therapy (P = 0.024), period of mechanical ventilation (P = 0.014), and period of sedation (P = 0.010). Our study is the first to provide detailed information on NCs after pLT in children under 24 months of age. The incidence of NCs in this particular group of very young patients was not increased compared to previously published data of children of all ages. Main NC was new‐onset seizure. In the surviving infants, prognosis of seizure was excellent and the risk of developing epilepsy was low. Even more, the occurrence of NCs did not significantly affect mortality or survival in this particular age group.</description><subject>Age</subject><subject>Brain Abscess - complications</subject><subject>Catecholamines</subject><subject>Catecholamines - therapeutic use</subject><subject>Children</subject><subject>Convulsions &amp; seizures</subject><subject>End Stage Liver Disease - complications</subject><subject>End Stage Liver Disease - surgery</subject><subject>Epilepsy</subject><subject>Female</subject><subject>Hematoma, Subdural - complications</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Incidence</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Infants</subject><subject>Liver diseases</subject><subject>Liver transplantation</subject><subject>Liver Transplantation - adverse effects</subject><subject>Liver transplants</subject><subject>Male</subject><subject>Mechanical ventilation</subject><subject>Medical prognosis</subject><subject>Mortality</subject><subject>Nervous System Diseases - complications</subject><subject>Neurological complications</subject><subject>Respiration, Artificial</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><subject>seizure</subject><subject>Seizures</subject><subject>Seizures - complications</subject><subject>Surgery</subject><issn>1397-3142</issn><issn>1399-3046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE9Lw0AQxRdRrFYvfgAJeBEhdTa7abLepNQ_UFSkPYfNZrakpNm4myj99m6b6sGDc5nH8JvHzCPkgsKI-rptsLUjyhjwA3JCmRChl-PDnU5CRnk0IKfOrQDomKf8mAwYMBqPqTghi1n5iTZoraxdU8m6lW1p6qDobFkvg7LWslabu-DFeK0sSodFYGWLgdFBjZ01lVmWSlaBMuum8mq77s7IkZaVw_N9H5LFw3Q-eQpnr4_Pk_tZqFic8LCgGlKlRF6kIuc5kymwvJCFQohTgYAiUiBA-imLUGjwZydaSFARprnmbEiue9_Gmo8OXZutS6ew8o-g6VwWUSoEg4SDR6_-oCvT2dpf5ykm4phxSDx101PKGucs6qyx5VraTUYh24adbcPOdmF7-HJv2eVrLH7Rn3Q9QHvgq6xw849V9jadv_em39aKioM</recordid><startdate>201812</startdate><enddate>201812</enddate><creator>Ameres, Markus</creator><creator>Melter, Michael</creator><creator>Zant, Robert</creator><creator>Schilling, Stefan</creator><creator>Geis, Tobias</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6941-3247</orcidid><orcidid>https://orcid.org/0000-0001-8092-3590</orcidid><orcidid>https://orcid.org/0000-0002-4194-0758</orcidid><orcidid>https://orcid.org/0000-0003-0604-332X</orcidid><orcidid>https://orcid.org/0000-0001-5053-5618</orcidid></search><sort><creationdate>201812</creationdate><title>Liver transplantation during infancy: No increased rate of neurological complications</title><author>Ameres, Markus ; Melter, Michael ; Zant, Robert ; Schilling, Stefan ; Geis, Tobias</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3574-d1f08cc9bd89b4b3a803bdadce0589e0e92c090a03b32e9f00317f9a0c2e8bf43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Age</topic><topic>Brain Abscess - complications</topic><topic>Catecholamines</topic><topic>Catecholamines - therapeutic use</topic><topic>Children</topic><topic>Convulsions &amp; seizures</topic><topic>End Stage Liver Disease - complications</topic><topic>End Stage Liver Disease - surgery</topic><topic>Epilepsy</topic><topic>Female</topic><topic>Hematoma, Subdural - complications</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Incidence</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Infants</topic><topic>Liver diseases</topic><topic>Liver transplantation</topic><topic>Liver Transplantation - adverse effects</topic><topic>Liver transplants</topic><topic>Male</topic><topic>Mechanical ventilation</topic><topic>Medical prognosis</topic><topic>Mortality</topic><topic>Nervous System Diseases - complications</topic><topic>Neurological complications</topic><topic>Respiration, Artificial</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><topic>seizure</topic><topic>Seizures</topic><topic>Seizures - complications</topic><topic>Surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ameres, Markus</creatorcontrib><creatorcontrib>Melter, Michael</creatorcontrib><creatorcontrib>Zant, Robert</creatorcontrib><creatorcontrib>Schilling, Stefan</creatorcontrib><creatorcontrib>Geis, Tobias</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ameres, Markus</au><au>Melter, Michael</au><au>Zant, Robert</au><au>Schilling, Stefan</au><au>Geis, Tobias</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liver transplantation during infancy: No increased rate of neurological complications</atitle><jtitle>Pediatric transplantation</jtitle><addtitle>Pediatr Transplant</addtitle><date>2018-12</date><risdate>2018</risdate><volume>22</volume><issue>8</issue><spage>e13304</spage><epage>n/a</epage><pages>e13304-n/a</pages><issn>1397-3142</issn><eissn>1399-3046</eissn><abstract>pLT is a highly standardized therapy for children with end‐stage liver disease and liver‐based metabolic diseases. However, NCs after transplantation occur and especially younger children are considered as more vulnerable and susceptible to NCs. Up to now, detailed data particularly for the very young age group do not exist. We therefore retrospectively studied NCs in children after pLT under age of 24 months. Forty children aged between 19 days and 22 months were evaluated according to type of NC and potential risk factors. NCs occurred in 8/40 patients (20%). All experienced new‐onset seizures and in 1/6 surviving patients, seizures evolved into epilepsy. Other NCs were intracerebral abscess (1/8 patients) and subdural hemorrhage (1/8 patients). The overall 3‐year mortality rate was 10% (4/40 patients). Significant risk factors for NCs and therefore seizures were HAT (P = 0.020), total surgery time (P = 0.009), retransplantation (P &lt; 0.001), period of catecholamine therapy (P = 0.024), period of mechanical ventilation (P = 0.014), and period of sedation (P = 0.010). Our study is the first to provide detailed information on NCs after pLT in children under 24 months of age. The incidence of NCs in this particular group of very young patients was not increased compared to previously published data of children of all ages. Main NC was new‐onset seizure. In the surviving infants, prognosis of seizure was excellent and the risk of developing epilepsy was low. Even more, the occurrence of NCs did not significantly affect mortality or survival in this particular age group.</abstract><cop>Denmark</cop><pub>Wiley Subscription Services, Inc</pub><pmid>30315619</pmid><doi>10.1111/petr.13304</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-6941-3247</orcidid><orcidid>https://orcid.org/0000-0001-8092-3590</orcidid><orcidid>https://orcid.org/0000-0002-4194-0758</orcidid><orcidid>https://orcid.org/0000-0003-0604-332X</orcidid><orcidid>https://orcid.org/0000-0001-5053-5618</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1397-3142
ispartof Pediatric transplantation, 2018-12, Vol.22 (8), p.e13304-n/a
issn 1397-3142
1399-3046
language eng
recordid cdi_proquest_miscellaneous_2119930740
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Age
Brain Abscess - complications
Catecholamines
Catecholamines - therapeutic use
Children
Convulsions & seizures
End Stage Liver Disease - complications
End Stage Liver Disease - surgery
Epilepsy
Female
Hematoma, Subdural - complications
Hemorrhage
Humans
Incidence
Infant
Infant, Newborn
Infants
Liver diseases
Liver transplantation
Liver Transplantation - adverse effects
Liver transplants
Male
Mechanical ventilation
Medical prognosis
Mortality
Nervous System Diseases - complications
Neurological complications
Respiration, Artificial
Retrospective Studies
Risk Factors
seizure
Seizures
Seizures - complications
Surgery
title Liver transplantation during infancy: No increased rate of neurological complications
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T09%3A25%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liver%20transplantation%20during%20infancy:%20No%20increased%20rate%20of%20neurological%20complications&rft.jtitle=Pediatric%20transplantation&rft.au=Ameres,%20Markus&rft.date=2018-12&rft.volume=22&rft.issue=8&rft.spage=e13304&rft.epage=n/a&rft.pages=e13304-n/a&rft.issn=1397-3142&rft.eissn=1399-3046&rft_id=info:doi/10.1111/petr.13304&rft_dat=%3Cproquest_cross%3E2119930740%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2139553407&rft_id=info:pmid/30315619&rfr_iscdi=true